SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-19-075693
Filing Date
2019-03-15
Accepted
2019-03-15 07:30:33
Documents
8
Period of Report
2019-04-24
Effectiveness Date
2019-03-15

Document Format Files

Seq Description Document Type Size
1 DEF 14A d706184ddef14a.htm DEF 14A 399237
2 GRAPHIC g706184ma1.jpg GRAPHIC 7812
3 GRAPHIC g706184ma2.jpg GRAPHIC 2279
4 GRAPHIC g706184ma3.jpg GRAPHIC 2088
5 GRAPHIC g706184ma4.jpg GRAPHIC 2657
6 GRAPHIC g706184ma5.jpg GRAPHIC 1992
7 GRAPHIC g706184pcll.jpg GRAPHIC 3204
8 GRAPHIC g706184pclr.jpg GRAPHIC 3199
  Complete submission text file 0001193125-19-075693.txt   433286
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
KEMPHARM, INC (Filer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36913 | Film No.: 19682929
SIC: 2834 Pharmaceutical Preparations